Related Experiment Video
Updated: Jun 15, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis
Heather Escoto1, Jeremy Ringewald, Ram Kalpatthi
1Division of Pediatric Hematology and Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America.
We report a male child with haemophagocytic lymphohistiocytosis who developed myocardial infarction after receiving etoposide. He recovered well with supportive measures and after discontinuation of etoposide. We discuss the possible mechanisms and differential diagnoses of myocardial infarction in our patient.
We report a male child with haemophagocytic lymphohistiocytosis who developed myocardial infarction after receiving etoposide. He recovered well with supportive measures and after discontinuation of etoposide. We discuss the possible mechanisms and differential diagnoses of myocardial infarction in our patient.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Overview
